Aggressive Prostate Cancer Tumors Controlled By Botanical ...

Editor?s Choice Academic Journal Main Category: Prostate / Prostate Cancer Also Included In: Urology / Nephrology Article Date: 29 Mar 2012 ? 8:00 PDT

email to a friend printer friendly opinions

Current Article Ratings:

4.67 (6 votes)

5 (2 votes)

The peer-reviewed pre-clinical in vivo study demonstrated that the prostate formula substantially suppresses tumor growth in aggressive, hormone-refractory (androgen-independent) human prostate cancer cells without any toxic side effects, even when administered at high doses. The formula is a combination of botanical extracts, phytonutrients, botanically enhanced medicinal mushrooms and antioxidants.

Inventor of the formula, Dr. Isaac Eliaz declared:

This is the third study from a major university which has demonstrated the formula?s ability to suppress tumor growth and metastasis.

Leading researcher Dr. Daniel Silva remarks:

The study results showed that in comparison to controls, the formula managed to suppress tumor growth by 27% and substantially reduced the size of the tumor. It also blocked several genes, i.e. IGF2, NRNF2 and PLAU/uPA, which encourage cancer proliferation and metastasis. It furthermore increased CDKN1A expression, a gene that fights prostate cancer by blocking cellular mechanisms that promote cancer.

Read more from the original source:

(1) Aggressive Prostate Cancer Tumors Controlled By Botanical Formula
URL: http://www.medicalnewstoday.com/articles/243540.php

Related Post

• Health Notes - BCBSNC announces challenge - March 30th, 2012
• Endo Announces Departure of American Medical Systems President - March 30th, 2012
• NovaBay Pharmaceuticals Provides Fourth Quarter and Full Year 2011 Financial Results - March 28th, 2012
• Antibody Helps in Rare Kidney Disorder Cases - March 23rd, 2012
• ANN ARBOR: U of M researcher Dr. David Miller receives $1.2M educational grant relating to urology - March 21st, 2012
• NovaBay Set for "Phenomenal Year" With Key Upcoming Clinical Data Announcements and Partnership Developments - March 21st, 2012
• Patients Overwhelmingly Support Care at Urology-Integrated Prostate Cancer Treatment Centers - March 21st, 2012
• Watson Confirms NIASPAN(R) Patent Challenge - March 19th, 2012
• March Madness Means Basketball, Pizza, and...Vasectomies? - March 17th, 2012
• Northwest News: March Madness = vasectomy time in Springfield; Alaska builder arrested in Texas in connection with ... - March 16th, 2012
• Endo Pharma Treads the Neutral Path - March 16th, 2012
• Medical Publisher Haymarket Media Launches Curated Video With Magnify.net Video Platform - March 15th, 2012
• Lunchtime Links: Mass. urology practice offers free pizza with vasectomy during March Madness - March 15th, 2012
• AUCNY Supports New Study Confirming the Need for Prostate Cancer Screening and Early Detection - March 15th, 2012
• Urology practice offers free pizza with vasectomy - March 15th, 2012
• Dr. Lyons to open urology practice - March 15th, 2012
• Specialized Care May Boost Cancer Survival (CME/CE) - March 15th, 2012
• Watson Confirms BYSTOLIC(R) Patent Challenge - March 15th, 2012
• Study Finds PSA Testing Cuts Prostate Cancer Death Risk - March 15th, 2012
• PSA Testing Still Has Value, Trial Suggests (CME/CE) - March 14th, 2012
• Sperm Quality Linked to Dietary Fat (CME/CE) - March 14th, 2012
• Can Circumcision Prevent Prostate Cancer? - March 13th, 2012
• Less Prostate Ca Seen in Circumcised Men (CME/CE) - March 12th, 2012
• Local Business Briefs - March 11th, 2012
• Zytiga Prednisone Combo Metastatic Castration-Resistant Prostate Cancer Trial Unblinded - March 11th, 2012
• Lab Notes: Sneezing? Open Up Spice Cabinet - March 9th, 2012
• Circumcision Tied to Drop in Herpes, Too - March 7th, 2012
• BPH Drugs Pose No Threat to Muscle Mass (CME/CE) - March 6th, 2012
• Cancer Screening Stats Not Well Understood (CME/CE) - March 6th, 2012
• DGAP-News: Analogic Showcases Three New BK Medical Ultrasound Systems With Groundbreaking Quantum Technology at ECR 2012 - March 2nd, 2012
• Endo Pharmaceuticals Announces Proposal to Change Name of Parent Company and Rebrands Enterprise: Revealing an ... - March 1st, 2012
• Cancer Mortality Down in Europe (CME/CE) - March 1st, 2012
• Lung, prostate and polon cancers decline across the U.S., but rise in Texas - March 1st, 2012
• PROGENSA? PCA3 featured at European Association of Urology Congress in Paris - March 1st, 2012
• Prostate Cancer Tx Up, but in Wrong Group (CME/CE) - February 29th, 2012
• Bladder Pain Syndrome - Gene Expression Analysis Shows Promise - February 28th, 2012
• Watson Receives Complete Response Letter from FDA for Progesterone Vaginal Gel 8% - February 28th, 2012
• Children?s National Medical Center Adds Robotic Surgery for Urology to Surgical Specialties - February 28th, 2012
• Study Finds NSAIDs May Increase Risk Of Prostate Cancer - February 28th, 2012
• FIRMAGON? (degarelix) demonstrates non-inferiority to goserelin with bicalutamide in reducing prostate volume in ... - February 28th, 2012

bernie madoff anna chapman kim kardashian honda generator honda generator cc sabathia ruth madoff